Methandienone oil by NovusLabs

• Effective substance: methandienone,
• Content: 75mg/ml
• Vial with: 10ml
• Known as: dbol, d-bol, danabol, dianabol
• Dosage: 75-150mg once every two days.
• Storage: Store in a dry, cool place. Protect from light and children.

Product Profile: Methandienone 75mg/mL (Novus Labs)

This profile provides a technical overview of the injectableMethandienone formulation produced by Novus Labs.

Chemical Identification

• Chemical Name: 17α17α-methyl-17β17β-hydroxyandrosta-1,41,4-dien-33-one
• Molecular Formula: C20H28O2C20​H28​O2​
• Molecular Weight: 300.44 g/mol300.44 g/mol
• Classification: 17α17α-alkylated Anabolic-Androgenic Steroid (AAS)

Formulation and Administration

• Concentration: 75 mg/mL75 mg/mL
• Vehicle: Sterile carrier oil (typically formulated for intramuscular injection).
• Administration: Intramuscular (IM) injection.
• Pharmacokinetics: Despite the oil-based delivery system, the parent Methandienone molecule does not possess an ester chain. Consequently, it maintains a short active half-life, typically ranging between 44 and 66 hours.

Pharmacological Profile

• Anabolic-Androgenic Ratio: 210:40–60210:40–60.
• Mechanism: Functions as a potent androgen receptor agonist. It facilitates rapid increases in protein synthesis, nitrogen retention, and glycogenolysis.
• Aromatization: The compound undergoes significant aromatization via the aromatase enzyme into 17α17α-methylestradiol, a highly potent estrogen. This often results in water retention and an increased risk of gynecomastia.

Safety and Usage Considerations

• Hepatotoxicity: Because the molecule is 17α17α-alkylated to survive hepatic metabolism, it remains hepatotoxic when injected. Chronic use or high dosages can result in significant elevations of liver enzymes (AST/ALTAST/ALT).
• Endogenous Suppression: The use of this compound will induce strong suppression of the Hypothalamic-Pituitary-Gonadal (HPG) axis, requiring a comprehensive recovery plan following the cessation of use.
• Cardiovascular Health: Frequent use is associated with adverse impacts on lipid profiles, specifically the lowering of HDL and the elevation of LDL cholesterol, as well as potential blood pressure increases.